We develop advanced deep-tech and AI imaging software to comprehensively assess bone microarchitecture and predict fracture risk in primary and secondary osteoporosis.
By leveraging Trabecular Bone Score, our multimodal imaging software empower clinicians to improve detection of bone fragilities, initiate treatment plans, and monitor response over time.
Clinician friendly
Designed with clinicians in mind, our software tools seamlessly integrate into clinical routine.
Patient-centric
Non-invasive and pain-free technology requiring no additional radiation and time for patients.
Time efficient
Fast processing time
freeing-up clinicians' time
to focus on
patient care.
The gold standard for osteoporosis fracture risk assessment
TBS Osteo is an AI-ready technology and state-of-the-art software powered by TBS iNsight to evaluate bone microarchitecture in patients during a DXA bone densitometry scan. It provides the missing link needed to identify more patients at risk of fracture.
Since 2022, TBS Osteo benefits from 4 dedicated CPT® codes for Medicare beneficiaries. Reimbursement under the PFS and OPPS have steadily increased in the USA.
TBS Osteo: a trusted bone health solution
TBS Osteo is trusted by more of the United States’ leading hospitals than ever before. Beyond its presence in all U.S. states and worldwide, along with its growing adoption in clinical routine, TBS Osteo is now present in 16 of the 20 hospitals ranked on the U.S. News Best Hospitals Honor Roll for 2024-2025.
This widespread adoption of TBS Osteo in the world’s foremost hospitals represents a pivotal juncture in clinical practice and bone health assessment across the globe. It marks a departure from conventional methods, where assessments primarily focused on BMD. Now, with TBS gaining prevalence in the world’s leading hospitals, there’s a tangible acknowledgment of the significance of considering not just density but also the bone microarchitecture.
TBS provides additional beneficial clinical insights into fracture risk. We routinely report TBS on virtually everyone. TBS is really the first major DXA advance in years.
Prof. Neil Binkley, Department of Medicine University of Wisconsin, Madison, USA
Assessing information related to bone microarchitecture in addition to bone density and clinical risk factors provides a more complete assessment to inform management decisions for the benefit of the patient.
Prof. E. McCloskey, Department of Oncology and Metabolism at Sheffield University, UK
TBS Osteo has become the standard of care at HSS.
Dr. Elaine Cong, Endocrinologist, Hospital for Special Surgery - River Terrace, New York, USA
4M
worldwide procedures/year
30
guidelines
90
countries
1400
publications
TBS Osteo next generation
By directly measuring soft tissue thickness, TBS Osteo next generation software can account for body size phenotypes and reach more of the patient population.
Learn more
TBS Reveal
TBS Reveal offers a proactive cost-effective method for widespread bone health assessment. This software utilizes existing images from conventional X-ray and CT acquisitions.
Learn more
medimaps group SA
Chemin du Champ-des-Filles 36A
1228 Plan-les-Ouates
Geneva, Switzerland
Medimaps Group USA LLC
1201N Market Street
Suite 111
Wilmington, DE 19801, United States
Medimaps Group has been certified by BSI to ISO 13485:2016 under certificate number MDR 799726. TBS iNsight is a trademark of Medimaps Group. TBS iNsight™ is cleared for sale in the U.S.
